Named on 2 rounds in the feed.
Rounds from 2026-08-31 to 2026-09-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Typewriter Therapeutics A biotech developing re-dosable, all-RNA gene-insertion therapies, including in vivo CAR T, for cancer, autoimmune and severe genetic diseases | Series A Verified against 4 of 9 sources | $56M | 2026-09-02 | [ PART ] |
Diffraqtion A quantum imaging startup | Pre-seed Verified against 4 sources | $5M | 2026-08-31 | [ PART ] |